Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Meningitis, Serogroup A”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Testing effectiveness (Phase 2)Study completedNCT02946385
What this trial is testing

Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 604
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Post-approval studies (Phase 4)Study completedNCT00119080
What this trial is testing

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
Centers for Disease Control and Prevention 4,000
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Testing effectiveness (Phase 2)Study completedNCT00962624
What this trial is testing

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Who this might be right for
Meningococcal Meningitis, Serogroup AMeningococcal Meningitis, Serogroup BMeningococcal Meningitis, Serogroup C+2 more
Prof. Elizabeth Miller 38
Testing effectiveness (Phase 2)Study completedNCT03295318
What this trial is testing

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Who this might be right for
Meningitis, Meningococcal
Serum Institute of India Pvt. Ltd. 375
Testing effectiveness (Phase 2)Study completedNCT01461980
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,648
Large-scale testing (Phase 3)Study completedNCT00616421
What this trial is testing

Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Who this might be right for
Meningococcal Infections
Novartis Vaccines 2,907
Large-scale testing (Phase 3)Study completedNCT01973218
What this trial is testing

Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.

Who this might be right for
Meningococcal Disease
Novartis Vaccines 264
Testing effectiveness (Phase 2)Study completedNCT01323270
What this trial is testing

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Who this might be right for
Meningococcal VaccinerLP2086Repevax+2 more
Pfizer 753
Post-approval studies (Phase 4)Study completedNCT01119482
What this trial is testing

Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
London School of Hygiene and Tropical Medicine 33,000
Large-scale testing (Phase 3)Study completedNCT00443846
What this trial is testing

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Who this might be right for
Meningitis, MeningococcalRotavirus Infections
Merck Sharp & Dohme LLC 247
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Testing effectiveness (Phase 2)Study completedNCT00771849
What this trial is testing

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 103
Post-approval studies (Phase 4)Study completedNCT01593514
What this trial is testing

Understanding the Immune Response to Two Different Meningitis Vaccines

Who this might be right for
MeningitisMeningococcal DiseaseSepticaemia
University of Oxford 20
Not applicableStudy completedNCT01452464
What this trial is testing

Safety of MenACWY-CRM Vaccination in Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 55,397
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Load More Results